Ascofuranone
WikiDoc Resources for Ascofuranone |
Articles |
---|
Most recent articles on Ascofuranone Most cited articles on Ascofuranone |
Media |
Powerpoint slides on Ascofuranone |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Ascofuranone at Clinical Trials.gov Clinical Trials on Ascofuranone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Ascofuranone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Ascofuranone Discussion groups on Ascofuranone Patient Handouts on Ascofuranone Directions to Hospitals Treating Ascofuranone Risk calculators and risk factors for Ascofuranone
|
Healthcare Provider Resources |
Causes & Risk Factors for Ascofuranone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Ascofuranone is an antibiotic that inhibits the Trypanosoma brucei alternative oxidase and is a lead compound in efforts to produce other drugs targeting this enzyme for the treatment of sleeping sickness.[1] The compound is effective both in vitro cell culture and in infections in mice.[2]
Ascofuranone has also been reported to have anti-tumor activity,[3] and modulate the immune system.[4]
References
- ↑ Minagawa N, Yabu Y, Kita K, Nagai K, Ohta N, Meguro K, Sakajo S, Yoshimoto A (1997). "An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei". Mol. Biochem. Parasitol. 84 (2): 271–80. PMID 9084049.
- ↑ Yabu Y, Yoshida A, Suzuki T, Nihei C, Kawai K, Minagawa N, Hosokawa T, Nagai K, Kita K, Ohta N (2003). "The efficacy of ascofuranone in a consecutive treatment on Trypanosoma brucei brucei in mice". Parasitol. Int. 52 (2): 155–64. PMID 12798927.
- ↑ Magae J, Hayasaki J, Matsuda Y, Hotta M, Hosokawa T, Suzuki S, Nagai K, Ando K, Tamura G (1988). "Antitumor and antimetastatic activity of an antibiotic, ascofuranone, and activation of phagocytes". J. Antibiot. 41 (7): 959–65. PMID 3417568.
- ↑ Magae J, Suzuki S, Nagai K, Yamasaki M, Ando K, Tamura G (1986). "In vitro effects of an antitumor antibiotic, ascofuranone, on the murine immune system". Cancer Res. 46 (3): 1073–8. PMID 3080231.